Troyen A Brennan
CIK 1351402 · EVP and Chief Medical Officer · last filed 2022-04-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$25.25M
Companies
1
Total Filings
50
Lifetime Open-Market Net
-$66.35M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CVS | EVP and Chief Medical Officer | 234,855 | $107.50 | $25.25M | -$66.35M | 46 | 2022-04-05 |
Recent Filings · Page 4 of 5
50 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-03-03 | CVS | Grant (A) | +13,839 | $1.44M | EDGAR |
| 2015-01-05 | CVS | Mixed | — | -$3.05M | EDGAR |
| 2014-03-31 | CVS | Sell (S) | −18,867 | -$1.40M | EDGAR |
| 2014-02-20 | CVS | Grant (A) | +16,353 | $1.15M | EDGAR |
| 2013-11-18 | CVS | Mixed | −15,254 | -$2.32M | EDGAR |
| 2013-04-16 | CVS | Mixed | — | -$3.51M | EDGAR |
| 2013-04-03 | CVS | Mixed | +8,771 | $478.3K | EDGAR |
| 2013-03-20 | CVS | Mixed | — | -$611.7K | EDGAR |
| 2013-02-21 | CVS | Grant (A) | +7,549 | $397.5K | EDGAR |
| 2012-04-04 | CVS | Mixed | +14,092 | -$177.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.